Major adverse cardiovascular events in a real-life COPD patient population

被引：0
|
作者：
Michotte, Naomi [1 ]
Hanon, Shane [1 ]
Verbanck, Sylvia [1 ]
Vanderhelst, Eef [1 ]
机构：
[1] Univ Hosp Brussels, Jette, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA1760
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The 'real-life' COPD patient in Germany: The DACCORD study
    Worth, Heinrich
    Buhl, Roland
    Criee, Carl-Peter
    Kardos, Peter
    Mailaender, Claudia
    Vogelmeier, Claus
    RESPIRATORY MEDICINE, 2016, 111 : 64 - 71
  • [2] Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database
    De Nunzio, Cosimo
    Nacchia, Antonio
    Grimaldi, Maria C.
    Turchi, Beatrice
    Rovesti, Lorenzo
    Franco, Antonio
    Guarnotta, Giorgio
    Voglino, Olivia
    Mancini, Elisa
    Baldassarri, Valeria
    Lombardo, Riccardo
    Cicione, Antonio
    Tubaro, Andrea
    MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (02): : 203 - 209
  • [3] Dupilumab in real-life settings: a review of adverse events and their pathogenesis
    Camela, Elisa
    Giampetruzzi, Anna Rita
    De Pita, Ornella
    Pallotta, Sabatino
    Russo, Filomena
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (04) : 439 - 447
  • [4] Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with COPD and Cardiovascular Risk Factors
    Wise, R. A.
    Scirica, B. M.
    Schoenfeld, D. A.
    Daoud, S. Z.
    Roman, J.
    Reisner, C.
    Gil, E. Garcia
    Chapman, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management
    Vallerio, P.
    Orenti, A.
    Tosi, F.
    Maistrello, M.
    Palazzini, M.
    Cingarlini, S.
    Colombo, P.
    Bertuzzi, M.
    Spina, F.
    Amatu, A.
    Lombardo, R.
    Prata, I
    Scaglione, F.
    Vighi, G. D.
    Severgnini, B.
    Siena, S.
    Giannattasio, C.
    Boracchi, P.
    Sartore-Bianchi, A.
    ESMO OPEN, 2022, 7 (01)
  • [6] Real-Life Insight Into Ibrutinib Cardiovascular Events Defining the Loose Ends
    Bergler-Klein, Jutta
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : 1679 - 1681
  • [7] Real-life data on COPD treatment
    Karimi, Leila
    Baan, Esme J.
    Geeraerd, Tiana
    Van der Lei, Johan
    Stricker, Bruno H. C.
    Brusselle, Guy G.
    Lahousse, Lies
    Verhamme, Katia M.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [8] Reply: Association between triple therapy and major adverse cardiovascular events in COPD patients
    Yang, Ming-Jin
    Guo, Shu-Liang
    Sin, Don D.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (03)
  • [9] REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) AND IMPROVEMENT OF ERECTILE FUNCTION IN HYPOGONADAL MEN RECEIVING TESTOSTERONE THERAPY - REAL-LIFE EVIDENCE FROM A REGISTRY STUDY
    Saad, F.
    Haider, K. S.
    Haider, A.
    Doros, G.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S164 - S165
  • [10] Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation
    Pignatelli, P.
    Pastori, D.
    Lip, G.
    Violi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 392 - 392
12345